, cells specifically required TGFb1 and IL-10. Add-back experiments showed that monocytes expressing increased levels of co-stimulatory molecules were sufficient for iRBC-mediated induction of Foxp3 in CD4 T cells. Foxp3 induction was driven by IL-2 from CD4 T cells stimulated in an MHC class II-dependent manner. However, transwell separation experiments showed that direct contact of monocytes with the cells that acquire Foxp3 expression was not required. This novel TCR-independent and therefore antigen-non specific mechanism for by-stander CD4 +
+

CD25
+ Foxp3 + Tregs are increased during malaria infection. The mechanisms governing their generation, however, remain to be elucidated. In this study we investigated the role of commonly accepted factors for Foxp3 induction, TCR stimulation and cytokines such as IL-2, TGFb and IL-10, in the generation of human CD4 , cells specifically required TGFb1 and IL-10. Add-back experiments showed that monocytes expressing increased levels of co-stimulatory molecules were sufficient for iRBC-mediated induction of Foxp3 in CD4 T cells. Foxp3 induction was driven by IL-2 from CD4 T cells stimulated in an MHC class II-dependent manner. However, transwell separation experiments showed that direct contact of monocytes with the cells that acquire Foxp3 expression was not required. This novel TCR-independent and therefore antigen-non specific mechanism for by-stander CD4 +
hi Foxp3 + cell induction is likely to reflect a process also occurring in vivo as a consequence of immune activation during malaria infection, and potentially a range of other infectious diseases.
Introduction
Malaria is one of the most important infectious diseases in humans, affecting 300-600 million people annually with more than a million fatal cases per year [1] . Infection with the Plasmodium parasite occurs hand in hand with a disturbance of immune homeostasis. While malaria is associated with severe immune-mediated pathology due to excessive inflammatory responses to the erythrocytic stage of the parasite [2] , impaired T cell responses are also a hallmark of acute malaria infection [3] [4] [5] [6] [7] . CD4
+ regulatory T cells (Tregs) are important players in maintaining immune homeostasis and controlling excessive immune responses [8] , and disproportionate induction or expansion of Tregs may also explain the immunosuppressive state during acute malaria infection [9] . Indeed, while functions attributed to these cells differ greatly depending on the experimental model used, increased numbers of CD4
Foxp3
+ T cells have been found in both human [10] [11] [12] [13] and murine [14] [15] [16] [17] [18] 
+ T cells can result either from the expansion of thymic-derived natural Tregs or from the de novo induction from previously naïve T cells. The de novo induction of the Treg-associated transcription factor Foxp3 in naïve human CD4 T cells has to date mainly been examined in in vitro systems using artificial stimuli such as TCR ligation via anti-CD3 in the presence of exogenously added recombinant cytokines including IL-2 and TGFb [19, 20] . The mechanisms of Treg induction by the malaria parasite, however, and the potential contribution of the above factors (TCR stimulation, IL-2 and TGFb) remain unknown.
TGFb as well as IL-10 are functional mediators of immunosuppression [20] [21] [22] [23] [24] [25] and have additionally been shown to play an important role in controlling excessive immune responses during malaria infection [15, [26] [27] [28] [29] [30] [31] [32] . Moreover, production of IL-10 during the early acute phase of infection is associated with an increased proportion of splenic CD4 +
CD25
+ T cells in non-lethal P. yoelii infection [28] . In humans, an early peak of bioactive serum TGFb precedes the up-regulation of CD4 +
+ T cells and Foxp3 mRNA levels in whole peripheral blood mononuclear cells (PBMCs) [11] . While these studies suggest the involvement of IL-10 and TGFb in CD4 + CD25 + Treg induction during malaria, no causal connection has been proven to date. Studies on human subjects often only allow looking at Treg numbers and cytokine levels at limited time points after infection and more importantly do not allow any intervention. Therefore, in vitro assays reflecting in vivo processes as closely as possible are needed to examine the mechanisms involved in the malaria parasite-mediated generation of CD4
Foxp3
+ human T cells. In this study, we have examined the contribution of monocytemediated TCR stimulation and cytokines including IL-2, IL-10 and TGFb to the induction of CD4 +
CD25
+ Foxp3 + T cells using an in vitro co-culture system of trophozoite-stage malaria-infected red blood cells (iRBC) with PBMCs from healthy donors in the absence of any further stimulation or addition of exogenous cytokines. We found that iRBCs, at concentrations typically found during mild/uncomplicated human malaria infection [12, 13] 
hi Foxp3 hi T cells on IL-10 and TGFb demonstrated here further highlights the importance of these immuno regulatory cytokines during malaria infection. Importantly, direct monocyte contact was only required with bystander CD4 + T cells for the generation of soluble mediators, but not with the future Foxp3 expressing T cells themselves. These findings have implications beyond malaria infection, as they demonstrate that Foxp3 induction, contrary to current belief, is not necessarily confined to cells subjected to direct antigen-presenting cell (APC) mediated TCR stimulation. Figure 1A ). Within the CD25 hi gate, two populations could be distinguished based on their Foxp3 expression levels ( Figure 1A ). The existence of the two populations was further confirmed with a second anti-Foxp3 mAb (clone 259D, data not shown). While isotype/background staining was elevated on all CD25
Results
Time
+ CD4 T cells in day 6 cultures, specific Foxp3 staining was only observed in the CD25
+/hi population ( Figure 1B T cells was dependent on the amount of iRBC added to the culture and increased with rising iRBC:PBMC ratios ( Figure 1D ; P,0.0001, one-way ANOVA with linear trend post-test). The ratios used were calculated to reflect a range of natural concentrations typically found in the peripheral blood of malaria-infected individuals with low to medium parasitemia [12, 13] Figure 1E ). Overall levels of Foxp3 expressing cells increased until day 6 of iRBC coculture ( Figure 1E ), and were stable up to day 8 (3 out of 3 donors, data not shown). In co-cultures with nRBCs or in the absence of RBCs, CD25 and Foxp3 expression levels remained unchanged throughout the whole culture period ( Figure 1E and data not shown) and were similar to those on freshly isolated CD4 T cells ( Figure 2B ). Unless otherwise stated, day 6 was used as the time point for analysis in subsequent experiments. + T cells also contained higher mRNA levels of the immunosuppressive cytokines IL-10 (P = 0.04) and TGFb1 (P = 0.002) than CD25 2 Foxp3 2 CD4 T cells (Figure 2A ). Phenotyping of the CD25 hi Foxp3 hi and Foxp3 int populations on day 6 of co-culture (2:1 iRBC:PBMC ratio) showed a largely similar phenotype compared with conventional natural CD25 + Foxp3 + Tregs (nTregs) in freshly isolated PBMCs (on day 0). All three populations expressed reduced levels of CD127 (IL-7R alpha ) and CCR7, and enhanced levels of CTLA-4, CD122 (IL-2R beta ), CD45RO, HLA DR and CD39 compared to
Author Summary
Infection with the malaria parasite Plasmodium falciparum affects 300-600 million people each year. Regulatory T cells (Tregs) expressing the transcription factor Foxp3, which drives genes involved in immunosuppression, are specialized immune cells that can inhibit both protective and harmful inflammatory responses during malaria. While Treg numbers are increased during malaria infection, little is known about how they are induced by the parasite. We addressed this question using an in vitro culture system to model the interaction of the malaria parasite with human immune cells. We found that the parasite induced soluble immune mediators, including the T cell growth-factor IL-2 and the regulatory proteins IL-10 and TGFb, which drive the induction and expansion of Tregs. These Tregs expressed high levels of Foxp3 and suppressed the production of inflammation and protective immunitydriving mediators by concurrently induced effector T cells. Importantly, we demonstrate that induction of Tregs by the malaria parasite did not necessarily require direct contact with antigen-presenting cells. Our findings suggest that the parasite induces Tregs in an antigen nonspecific manner, which may explain why malarial immunosuppression is not confined to malaria-specific immune responses, and provide new insights into the mechanisms governing Treg induction during malaria infection, and potentially other infectious diseases. 
CD25
2 T cells for each donor (A). PBMC of 3 donors were phenotyped on day 0 prior to iRBC-PBMC co-culture set up, and after 6 days of iRBC:PBMC co-culture (2:1 ratio). Dot plots show the gating strategies for Foxp3 expressing cells on day 0 and day 6, respectively (B). Representative histograms depicting isotype control staining (grey filled) and specific staining for various surface markers on CD25 We further utilized the combination of intracellular Foxp3 and Th effector cytokine staining as a means to gain insight into the potential suppressive activity of the Foxp3 hi population, whilst avoiding the necessity to purify the different subsets (which is not possible due to the lack of suitable surface markers to differentiate between the otherwise intracellularly stained Foxp3 hi and effectorlike Foxp3 int cells). Specifically, we asked whether changes in the relative proportion of induced Foxp3 hi to Foxp3 int cells would affect the ability of the Foxp3 int population to produce Th effector cytokines. We concentrated on the Th1 and Th2 effector cytokines IFNc and IL-4, which play important roles in anti-malarial immunity and immunopathology [37] [38] [39] [40] , as well as the Th17 cytokine IL-17, which promotes the recruitment of neutrophils [41] that contribute to the clearance of malaria-infected RBCs as well as malaria pathogenesis [42, 43] 
T cell population
We next tested whether iRBC-induced Foxp3 hi and Foxp3 int cells were derived from proliferating CD4 T cells. PBMCs were labelled with CFSE and analysed on day 6 for CFSE dilution and Foxp3 expression within the CD4 T cell compartment ( Figure 4A ). As shown in Figure 4B , 79+/24.1% of Foxp3 int and 82.2+/ 23.4% of Foxp3 hi CD4 T cells (Mean+/2SEM) had proliferated within the 6 days of iRBC co-culture. When examining CFSE dilution and Foxp3 expression continuously over a time course of 6 days, we found that Foxp3 expression was initially up-regulated in the absence of proliferation, followed by proliferation resulting in a steady increase in both Foxp3 hi and Foxp3 int subsets ( Figure 4C ). We next investigated whether the two Foxp3 + populations could be induced from CD25 2 CD4 T cells, and whether there was a contribution from potentially expanding CD25
+
Foxp3
+ CD4 nTregs present in the initial PBMC population. To answer this question, PBMCs were depleted of CD25
+ cells prior to onset of the iRBC:PBMC co-culture, with an average depletion efficiency of CD25
+
Foxp3
+ nTregs by 93.8+/22% (Mean+/2SEM) ( Figure 4D ). As shown in Figure 4E , CD25 hi
hi and CD25
hi Foxp3 int were induced from both whole and CD25 depleted PBMC with similar kinetics. However, we found that in 11/15 donors, CD25 depletion prior to onset of iRBC:PBMC coculture led to a significant decrease (ranging from 6-72%, Figure 4F and data not shown) in the bulk iRBC-induced CD25 hi compartment rather than within the complete CD4 T cell population. We found that overall there was a significant reduction in the iRBC-induced proportion of Foxp3 hi cells within the CD4 + CD25 + T cell population in iRBC co-cultures with CD25 depleted PBMCs (Median 6.2%; interquartile range 2.3-10.2) compared to whole PBMCs (Median 7.3%; interquartile range 6.1-12.1; P = 0.015, Figure 4G ). Monocytes expressing increased levels of co-stimulatory molecules are sufficient for iRBC-mediated induction of Foxp3 expression
Foxp3 expression in CD4 T cells was not induced when purified T cells as opposed to whole PBMCs were co-cultured with iRBCs, demonstrating that induction of Foxp3 + CD4 T cells is not due to a direct interaction of T cells with iRBCs but dependent on other cells present in the co-culture system ( Figure 5A ). APCs have been suggested to play a fundamental role in the induction of Tregs [44] , and monocytes are the most abundant APCs in human peripheral blood. To evaluate the possibility that monocytes interacting with iRBCs were responsible for the induction of Foxp3 + CD4 T cells, we co-cultured purified T cells with positively selected CD14
+ monocytes at ratios consistent with the original proportions of T cells and monocytes in whole PBMCs determined for each donor. As shown in Figure 5A , CD14 + monocytes were sufficient to induce CD25 induction of Foxp3 expression (P,0.001, one-way ANOVA with Neuman-Keuls' post-test) ( Figure 5B). When examining the activation status of CD14 + monocytes in iRBC:PBMC co-cultures, we found that the levels of co-stimulatory molecules CD80, CD40 and CD86 were higher when iRBCs, but not nRBCs were added to the co-culture (P,0.01, one-way ANOVA with Dunett's posttest; Figure 5D ), suggesting strong T cell co-stimulatory capacity. iRBC-mediated induction of CD80 and CD86, but not CD40 on monocytes was further dose-dependent, with lower expression levels at a 1:5 compared to a 2:1 iRBC:PBMC ratio.
iRBC-mediated induction of Foxp3 expression in converting CD4
+ T cells requires MHC class II-induced soluble factors but not direct contact with monocytes A possible molecular basis for the dependency of Foxp3 induction on contact between T cells and monocytes could be the interaction of monocyte-expressed MHC class II/peptide complexes with the TCR of CD4 + T cells. Indeed, blocking Abs directed against HLA DR (clone L243) inhibited the induction of Foxp3 expression ( Figure 6A ; P,0.001, one-way ANOVA with Neuman-Keuls' post-test). Blocking MHC class II-TCR interaction additionally severely reduced day 2 IL-2 levels and day 6 IL-10 levels in iRBC:PBMC co-culture supernatants (P,0.01) ( Figure 6B ).
This raised the question whether the disruption of Foxp3 induction was due to the lack of MHC class II-induced soluble factors such as IL-2 and IL-10 produced by intermediate/ bystander T cells, or to the lack of direct MHC class II interaction with the converting T cells themselves. To test these two possibilities, purified T cells were again separated from iRBC co-cultured monocytes through a transwell. Surprisingly, induction of CD25
hi Foxp3 hi and to a lesser degree also CD25 hi Foxp3 int CD4 + T cells outside the transwell could be partially restored when iRBC co-cultured monocytes inside the transwell insert were supplemented with T cells or replaced with iRBC co-cultured PBMCs (containing both T cells and monocytes) (P,0.001, oneway ANOVA with Neuman-Keuls' post-test; Figure 7A and B). There was no significant difference between the proportion of induced CD25 hi
Foxp3
hi and CD25 hi Foxp3 int cells whether iRBC:monocyte:T cell co-cultures were set up inside or in the absence of a transwell ( Figure 7A and B) . Interestingly, Foxp3 hi :Foxp3 int ratios were significantly higher (P,0.05, oneway ANOVA with Neuman-Keuls' post-test) in CD4 + CD25 hi T cells induced across the transwell in the absence of direct We further examined which particular population of bystander T cells interacted with monocytes to promote the induction of Foxp3 expression across the transwell. We addressed this question by depleting purified T cells of anti-CD8, CD4 or CD25 single stained cells via FACS sorting to leave the T cells, which interact with the monocytes, untouched to avoid any possible interference of surface antibodies on T cells with their function. Depleted T cells were then added back to monocytes within the transwell at the original ratios as determined in whole PBMCs for each donor. As shown in Figure 7E , only CD8 depleted (i.e. CD4 + T cells), but not CD4 depleted (i.e. CD8
+ T cells) interacting with monocytes within the transwell were capable of inducing Foxp3 expression across the transwell. In line with this, only the interaction of CD8 depleted (CD4 + ), but not CD4 depleted (CD8 + ) T cells with monocytes resulted in the secretion of IL-2 and IL-10 into the cell culture supernatant (Figure 7E ), consistent with MHC class II dependency of these two cytokines as shown in Figure 6B . int subset compared to CD4 T cells in direct co-cultures ( Figure 8A ), which is consistent with the results from the internal suppression assay shown in Figure 3B . We further analyzed the phenotype of Foxp3 hi and Foxp3 int cells induced in the direct co-culture or the transwell system and compared their phenotype to CD25
+
Foxp3
+ nTregs from freshly isolated PBMCs prior to iRBC co-culture ( Figure 8B ). Induced CD25 hi Foxp3 hi and CD25 hi Foxp3 int cells in both culture systems had a very similar phenotype in regards to CD127, CD45RO and CD39 expression. TNFRII, ICOS and CTLA-4 expression was higher in Foxp3 hi compared to Foxp3 int cells in both direct and transwell-separated cultures, however, overall expression levels of these markers were 5-30 fold lower in Foxp3 expressing T cells induced in transwell-separated compared to direct cultures and more similar to day 0 nTregs.
iRBC induce a pro-inflammatory cytokine milieu in combination with increased IL-10 and decreased TGFb1 levels
To further examine the role and nature of cytokines present in the co-culture system contributing to the induction of Foxp3 expression, we first characterized the iRBC-induced cytokine profile. As shown in Figure 9A , the pro-inflammatory cytokines IL-6 and IFNc and the anti-inflammatory cytokine IL-10 were induced as early as 24 h after the addition of iRBCs and remained at high levels throughout the duration of the co-culture. IL-2 levels in the supernatant peaked at day 2-3 of co-culture and then declined to barely detectable levels on day 5 and 6 ( Figure 9A ). None of these cytokines were detectable in the absence of iRBCs.
High levels of total TGFb1 (latent plus bioactive) were measured in the supernatant of untreated PBMCs on day 6 of culture, ranging from 0.6-13.5 ng/ml (23 donors; Median = 3.48 ng/ml; data not shown). Interestingly, day 6 TGFb1 levels were significantly decreased when PBMCs were co-cultured with iRBCs (12 donors, P,0.01 for 2:1 ratio and P,0.05 for 1:5 ratio, one-way ANOVA with Neuman-Keuls' post-test; Figure 9B ), but unchanged when PBMCs were co-cultured with uninfected RBCs (15 donors, data not shown). This decrease in total TGFb1 was already evident and significant from 24 hours of co-culture onwards (data not shown) and dependent on the amount of iRBCs added to the co-culture ( Figure 9B ; P,0.0001, one-way ANOVA with linear trend post-test). A decrease in total TGFb1 would be consistent with either increased conversion into bioactive TGFb and immediate consumption, or decreased production and secretion. To test the latter, TGFb1 mRNA levels for 2 donors were monitored over a time course of 6 days, showing no decrease in TGFb1 mRNA in iRBC co-cultured PBMCs compared to control cultures, but instead a 2-3 fold increase on day 5-6 of coculture (data not shown), suggesting a possible counter-regulatory mechanism to enhanced TGFb consumption and therefore decreasing TGFb protein levels in the cell culture supernatant. We next tested whether the high baseline levels of TGFb1 in the iRBC:PBMC co-cultures were due to autologous serum used to supplement the co-culture medium, or produced endogenously by cells within the co-culture system. While serum-supplemented medium did contain high levels of TGFb1 before addition of cells (day 0), TGFb1 levels increased over the first days of co-culture in both serum-supplemented and serum-free cultures, and reached comparable levels on day 6 of co-culture ( Figure 9C ). Further, there was no significant difference in the proportion of CD25 hi Foxp3 hi and CD25 hi Foxp3 int CD4 + T cells on day 6 of co-culture in serum-supplemented compared to serum-free iRBC:PBMC co-cultures ( Figure 9D) , and no induction of these cells was seen in the absence of iRBCs as expected (data not shown). Foxp3 induction did therefore not depend on serumderived exogenous TGFb1, and TGFb1 was produced by cells in the co-culture system.
To determine the cellular source of TGFb1 and IL-10 in iRBC:PBMC co-cultures, individual cell populations were FACSsorted on day 6 and analysed for TGFb1 and IL-10 mRNA levels expressed as normalized values compared to 18SrRNA, thus reflecting the average mRNA levels on a per cell basis. Across 3 donors tested, monocytes and CD3 2 CD56 + NK cells produced the highest amounts of TGFb1 mRNA ( Figure 10A ; P,0.05 according to one-way ANOVA with Neuman-Keuls' post-test). Monocytes (as well as CD4 T cells) were also the major source of IL-10 mRNA ( Figure 10A ). Therefore, iRBC-exposed monocytes had an alternatively activated phenotype with increased levels of co-stimulatory molecules whilst at the same time producing immune suppressive cytokines. When correcting mRNA levels of each population for the proportion of this population in whole PBMCs ( Figure 10B ), however, CD4 T cells were the predominant source of cellular TGFb1 and IL-10 mRNA in iRBC-treated PBMCs, closely followed by monocytes ( Figure 10C ). Moreover, in the absence of T cells, monocytes did not produce IL-10 upon iRBC exposure, and TGFb1 levels were unchanged in the supernatant of purified monocytes co-cultured with either iRBCs or nRBCs, indicating a need for interaction with T cells to produce these cytokines (data not shown).
IL-2 is required for Foxp3 induction in general, but only Foxp3 hi cells specifically require TGFb and IL-10
To test whether TGFb plays a role in the induction of Foxp3 
Discussion
CD4
+ CD25 + Foxp3 + Tregs were initially thought to mainly play a role in immune homeostasis to avoid autoimmunity, but are increasingly also attributed roles in controlling immune responses to non-self antigens [8] , thereby preventing immuno pathology, or alternatively contributing to immune evasion by tumors or invading pathogens [45] . An increase in peripheral CD4 + CD25
+
Foxp3
+ T cells has been observed in a number of infectious diseases including tuberculosis [46, 47] , hepatitis C [48] and helminth infections [49, 50] , as well as human [10] [11] [12] [13] and murine [14] [15] [16] [17] [18] malaria infection. Current in vitro models examining the factors contributing to peripheral induction and expansion of human or murine CD4 + CD25
+
Foxp3
+ T cells combine strong TCR-stimulation using anti-CD3 mAb, allogeneic or peptide pulsed APCs together with exogenously added cytokines IL-2 and TGFb [19, 20, [51] [52] [53] .
In this study, we set out to determine whether the above signals also govern the induction of Foxp3 expression in human CD4 T cells by malaria-infected RBCs in the absence of any other exogenous stimuli. We set up an in vitro co-culture system of freshly isolated human PBMCs and trophozoite-stage iRBCs at a range of 
CD25
+ natural Tregs, including the expression of immuno-suppressive mediator molecules such as CTLA-4 or CD39 [23] . In contrast to natural Tregs, they did, however, also express markers indicating recent activation. CD4
+ CD25 hi Foxp3 hi T cells additionally expressed higher levels of the Treg markers ICOS and TNFRII compared to Foxp3 int T cells. In line with this, Walther and co-workers recently also found a correlation between Foxp3 and TNFRII levels on Tregs from malaria infected children [13] , and Minigo and colleagues reported higher levels of TNFRII expression on Tregs from individuals with severe as opposed to uncomplicated malaria [12] . Out of the parasite-induced CD25 hi CD4 T cells, the Foxp3 hi population was practically devoid of pro-inflammatory cytokine producing cells consistent with a T regulatory phenotype. In contrast, the Foxp3 int population contained significant subsets of cells producing the major Th effector cytokines IFNc (Th1), IL-4 (Th2), IL-17 (Th17) as well as the T cell growth factor IL-2 consistent with an effector phenotype. The predominant cytokine produced by the Foxp3 int subset was the Th1 cytokine IFNc, consistent with a recent study by Walther and co-workers [13] . Moreover, we found a significant inverse correlation between determined by Foxp3 mRNA levels were recently shown to negatively correlate with the magnitude of malaria-specific memory IFNc responses in human malaria patients [13] . Moreover, an ethnic group in West Africa, the Fulani, shows a functional deficit in Treg related gene expression [54] , as well as elevated levels of peripheral blood malaria-specific Th1 (IFNc) and Th2 (IL-4) producing cells [55] .
The majority of both CD4 + CD25 hi Foxp3 hi and Foxp3 int T cells had proliferated and were also induced in iRBC:PBMC cultures previously depleted of natural CD4 +
+ Tregs, strongly suggesting their main origin in the CD4 + CD25 2 naïve T cell population, with an additional and independent contribution from natural Tregs to the parasite-induced generation of CD4 + CD25 hi -Foxp3 hi T cells. Future studies may further explore the potentially different functional properties or alternative pathways of generation of the subset of Foxp3 + T cells that failed to proliferate by day 6 of co-culture. Monocytes expressing increased levels of costimulatory molecules as well as IL-10 and TGFb mRNA were sufficient for iRBC-induced Foxp3 expression in purified T cells.
Importantly we demonstrate here for the first time, to our best knowledge, that direct TCR stimulation is not strictly required for Foxp3 induction in CD4 T cells by an infectious agent. The induction of Foxp3 expression occurred in transwell-separated responder/bystander T cells solely responding to soluble factors without their direct interaction with monocytes. The 20 nm pore size of the transwell inserts also eliminates the possibility that monocyte derived MHC class II-bearing exosomes, which are 50-100 nm in diameter, could have transferred antigen between the two chambers [56, 57] . A final possibility would be TCR stimulation resulting from direct T cell-to-T cell presentation of iRBC-derived peptides, possibly acquired from APC-derived soluble MHC as reported for CD8 + T cells [58] . This possibility can, however, also be excluded as Foxp3 induction did neither occur when T cells were directly cultured with iRBCs, nor when T cells were separated from iRBC-exposed monocytes, as a potential source of such peptides, through a transwell. Instead, monocyte/ MHC class II interaction with helper CD4 T cells was critical to initiate the secretion of the soluble mediators IL-2 and IL-10, which were necessary for the induction of Foxp3 hi expression in transwell-separated bystander CD4 + T cells (Figure 12 ). The generally lower levels of either Foxp3 int or Foxp3 hi T cells outside the transwell (compared to directly cultured cells) can at least partially be explained by the consumption of cytokines as well as other potential soluble mediators by CD4 T cells inside the transwell insert, converting into Foxp3
+ cells themselves. While we cannot exclude that soluble factors derived from TCR-stimulated T cells inside the transwell might additionally act in an autocrine fashion in concert with TCR-stimulation in these cells, this was clearly not the case for their counterparts outside the transwell.
These findings contrast the common assumption that peripheral induction of Foxp3 expression in CD4 + CD25 2 T cells necessarily requires stimulation through the TCR [20] . While it has been shown that the foxp3 gene has response elements that can positively regulate the trans activation of the foxp3 promoter after triggering Foxp3 Induction in Malaria of the TCR [59] [60] [61] , direct TCR stimulation through APCs, according to our data, is not an absolute requirement. The fact that the induction of Foxp3 expression in CD4 + T cells does not require direct contact of these cells with APCs such as monocytes via the TCR also implies that there is no mechanism to ensure that induction of Foxp3 expression is confined to T cells specific for the same antigen, as proposed elsewhere [20] . This in turn may explain why immune suppression during acute malaria infection, for instance, is not confined to T cell responses against malarial antigens, but also other pathogens such as Epstein Barr virus [5, 62] , Herpes Zoster virus [3] or Salmonella species [6] as well as vaccine antigens administered during and after acute malaria infections [4, 7] . CD25 hi Foxp3 hi and CD25 hi Foxp3 int cells generated outside the transwell without direct monocyte contact did further display similar functional characteristics compared to those induced in direct co-cultures, and similar expression levels of CD127, CD39 and CD45RO compared to day 0 CD25
+
Foxp3
+ nTreg and day 6 Foxp3 hi and Foxp3 int cells in direct co-cultures. However, while TNFRII, ICOS and CTLA-4 expression was higher in Foxp3 hi compared to Foxp3 int cells in both direct and transwell-separated cultures, overall expression levels of these markers were markedly lower in Foxp3 expressing T cells induced in transwell-separated cultures, indicating that high levels of expression of these molecules do require direct TCR or co-stimulation of these cells. In fact all three molecules are known to be up-regulated upon TCR stimulation, and CD80/CD86-mediated CD28 co-stimulation of T cells further increases CTLA-4 expression and is required for ICOS expression [63] [64] [65] [66] . Thus, while Foxp3 hi with a Treg phenotype and functional capacity, and to a lesser extend also effector-like Foxp3 int cells, can be induced across the transwell by soluble factors in a TCR independent manner, it is likely from these data that in direct co-cultures these cells do in fact receive a TCR/co-stimulatory signal that enhances expression levels of some, but not all surface markers including TNFRII and ICOS as well as intracellular CTLA-4.
Foxp3 hi :Foxp3 int ratios were higher in transwell separated T cells, most likely due to the stagnation of Foxp3 int levels but a further increase in Foxp3 hi levels from day 4 onwards. This suggests that the induction/expansion of Foxp3 int cells may be more reliant on cell-to-cell contact, while Foxp3 hi CD4 + T cells may be more easily induced and expanded by soluble factors in the co-culture system. Specifically, we found that both populations critically relied on monocyte/MHC class II-induced IL-2, which is consistent with the multiple roles of IL-2 in regulatory and inflammatory T cell responses [67] . However, only CD25
hi Foxp3 hi CD4 T cells, which were detectable 24 later than CD25
hi Foxp3 int cells, were also dependent on TGFb1 and IL-10. Interestingly, IL-10 and TGFb secreted by natural or induced Treg have been reported to convert naive CD4 T cells into Foxp3 expressing Tregs [68] . The importance of these two cytokines for the induction of CD4 + CD25 hi Foxp3 hi T cells may explain previous findings showing an association between IL-10 and TGFb production early during malaria infection and an increase in CD4 +
CD25
+ (Foxp3 + ) T cells [11, 12, 28] . Further, CD4 + T cells, and specifically those in the CD25 hi fraction, were the major cellular source of these two cytokines in iRBC-co-cultured PBMCs. In this context it was recently shown that effector T cells co-producing IFNc and IL-10, which are more prevalent in children with mild than severe malaria, may help to regulate acute malarial inflammation [13] . It is therefore a possibility that the more contact-dependent CD4 + CD25 hi Foxp3 int T cells constitute the above mentioned TCR-stimulated, cytokine secreting helper T cells (which via IL-2, IL-10 and potentially TGFb secretion subsequently act on responder/bystander T cells), thereby further promoting TCR-independent induction of CD4 +
hi Foxp3 hi T cells (summarized in Figure 12 ). Future studies using this in vitro iRBC:PBMC co-culture system can further investigate the potential roles of mediators other than MHC class II stimulation and TCR stimulation or the above cytokines in the induction of Foxp3 expression. Besides CD4 + CD25 hi T cells, monocytes in iRBC:PBMC cultures were a major source of the immuno modulatory cytokines IL-10 and TGFb1 in our study. This is in accordance with an earlier study on Treg induction in experimental malaria infection of healthy UK volunteers, which identified monocytes as the predominant source of early serum TGFb [11] . IL-10 production has equally been attributed to iRBC-exposed APCs [69] [70] [71] [72] . Interestingly, however, we found no detectable IL-10 in the supernatant of purified monocytes co-cultured with iRBCs in the absence of, or transwell-separated from T cells, and there was also no difference in supernatant TGFb levels between purified monocytes co-cultured with iRBCs or nRBCs (data not shown). This indicates that contact with T cells may be required for monocytes to produce these cytokines in response to iRBC exposure, and future studies are needed to further explore the interplay and potential reciprocal modulation between the two cell types.
iRBC-exposed monocytes also up-regulated expression of costimulatory molecules, which for CD80 and CD86 was dependent on the parasite dose. In pregnancy-associated malaria, iRBCs preferentially accumulate in the placenta leading to higher parasite exposure of placental compared to peripheral blood monocytes [73] , and CD80 and CD86 expression was higher in placental compared to peripheral monocytes [74] . The contribution of diverse parasite factors and their corresponding receptors on monocytes to monocyte activation and subsequent induction of Foxp3 expression will be an important subject of future studies and may involve molecules such as TLR9 [75] and the scavenger receptor CD36 [76] [77] [78] . The induction of Foxp3 expression in CD4 + T cells by APCs expressing the co-stimulatory molecules CD80 and CD86 is consistent with previous reports [53, 79] . CTLA-4 ligation via CD80 shortly after T cell activation is necessary to enable TGFb-induced Foxp3 expression [80] , and costimulation via CD28 has been shown to mediate survival of murine Tregs induced by TCR/TGFb1-stimulation [81] . Banerjee and co-workers further demonstrated that APCs are most effective in inducing functional Foxp3 + CD4 + T cells when treated with pro-inflammatory cytokines TNF, IL-6 and IL-1b [79] , all of which were detectable in the iRBC:PBMC co-cultures used in this study. Importantly, co-stimulation by APCs has been found to be necessary to induce T cell-derived IL-2, which is crucial for the induction of Foxp3 expression [44, 53] and consistent with the findings presented here. IL-2 does not, however, directly induce Foxp3, but is essential for TGFb1 induced Foxp3 expression in CD4 + CD25 2 T cells as well as their expansion [51] . Furthermore, IL-2 signaling via STAT5 through the IL-2Rb chain (CD122), which is expressed by both Foxp3 hi and Foxp3 int CD4
+ CD25 hi T cells in this study, has been shown to be crucial for Foxp3 expression and Treg function [82, 83] .
The fact that Foxp3 induction also occurred in iRBC:PBMC cultures previously depleted of natural CD4 + CD25 + Tregs is consistent with the origin of future Foxp3 + cells in the CD4 + CD25 2 naïve T cell population and supported by other studies describing this phenomenon [53, [84] [85] [86] . IL-2 dependent induction of Foxp3 in this population devoid of IL-2 receptor expression can be explained by the coordinated induction of CD25 by the parasite cytokine environment: IL-6, TNFa and TGFb for instance are all known to induce CD25 expression [66, [84] [85] [86] [87] [88] [89] , and IL-2 itself has been shown to promote gene expression of its own receptor [90] even in human CD25 depleted PBMC, i.e. in the absence of IL-2 receptor expression, on both CD4 + and CD8 + T cells in the absence of antigenic stimulation [91] . Thus, cytokines including TGFb and IL-2 as well as potential parasite-derived factors in iRBC:PBMC co-cultures may induce CD25 expression in naïve CD4 + CD25 2 T cells, rendering these cells responsive to IL-2, resulting subsequently in enhanced CD25 expression, IL-2 promoted Foxp3 induction and proliferation.
Decreased TGFb1 levels in the co-culture supernatants are consistent with increased consumption of TGFb and were evident as early as 24 hours after addition of iRBCs to PBMCs. The importance of early TGFb exposure for Foxp3 induction has been shown in vitro [52] and in experimentally malaria-infected human volunteers [11] . Furthermore, it has been observed that Tregderived surface TGFb or TGFb bound to latency associated peptide on the surface of induced Tregs [20] or immature DCs [92] can in turn induce Foxp3 expression in responder cells. The Fulani, an ethnic group in West Africa with a decreased susceptibility to P. falciparum malaria, have a deficit not only in Foxp3 but also TGFb, TGFbR mRNA expression in CD4 + CD25 + Tregs and lower serum TGFb levels [54] . This raises the question whether insufficient TGFb availability might contribute to the deficit in Foxp3 in these cells and hence the more potent antimalarial immune responses in this population.
In summary, we examined and defined the contribution of host immune mechanisms including APC-mediated TCR stimulation and cytokines to the induction of Foxp3 expression by the malaria parasite. Using an in vitro co-culture system of purified parasitized 
+ Foxp3 + cells is, in contrast to current belief, not necessarily linked to direct antigenspecific TCR stimulation. Future studies are now required to determine whether other pathogens are also able to induce such cells without the need for direct and concomitant TCR stimulation.
Materials and Methods
P. falciparum culture and trophozoite isolation
Mycoplasma-free blood-stage parasites of Plasmodium falciparum (strain 3D7) were maintained in O + erythrocytes in RPMI-1640 medium (JRH, Lenexa, KS, USA) supplemented with 1 mM glutamine, 11 mM glucose, 25 mM HEPES, 0.2% (w/v) sodium bicarbonate, 200 mM hypoxanthine, 40 mg/ml gentamycin (all Sigma-Aldrich, St. Louis, MO, USA), and 0.5% (w/v) AlbuMAX II (GIBCO, Invitrogen, Carlsbad, CA, USA) at 37uC in an atmosphere of 5% CO 2 and 1% O 2 in N 2 . Knob-expressing parasites were enriched weekly using gelofusine solution (Braun Melsungen, Germany). Trophozoite stage parasites were isolated by density gradient centrifugation following layering onto a gradient of 40/60/80% isotonic Percoll (Amersham Biosciences, Uppsala, Sweden). The percentage of infected erythrocytes was typically 90-100%.
PBMC isolation and iRBC:PBMC co-culture
PBMCs were recovered by Ficoll-Hypaque (Amersham Biosciences) density gradient centrifugation from buffy coats (Australian Red Cross Blood Service, Melbourne, Australia). Autologous human serum (HS) was obtained by coagulating platelet-rich plasma from buffy coats with 0.3% (w/v) CaCl 2 , followed by heatinactivation at 56uC for 30 min. PBMCs were cultured in AIM-V medium (GIBCO, Invitrogen) supplemented with 5% autologous HS alone (untreated controls), with non-infected control erythrocytes or trophozoite-stage iRBCs. iRBC:PBMC ratios were calculated to reflect parasitemia ranges in natural infections (2:1 ratio ,0.1% parasitemia or 5000 iRBC/ml blood; 1:5 ratio ,0.01%; 1:50 ratio ,0.001%), assuming an average RBC count of 6610 6 /ml blood and 3610 3 PBMCs/ml blood (white blood cell count minus granulocytes). In some experiments, tissue culture inserts (Anopore, NUNC, Naperville, IL, USA) were used to separate iRBC-treated (inside) and untreated cell populations (outside the transwell). A pore size of 20 nm was chosen to prohibit transfer of hemozoin crystals, which are on all sides larger than this cut-off [93] .
Magnetic cell isolation and add-back experiments
PBMCs were separated using the Pan-T cell negative isolation kit and CD14 microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturer's recommendations in combination with LS (negative selection), MS (positive selection) and LD (depletion) columns. T cells and monocytes were typically .97% pure. CD14
+ monocytes were added back to purified T cells based on original donor-specific ratios as determined by flow cytometry analysis for each donor. CD3 + T cells ranged from 45-57% and CD14
+ monocytes from 7-31% of total PBMCs. For some experiments, PBMCs were depleted of CD25 + cells using anti-CD25 PE antibody (BD Pharmingen) and anti-PE microbeads (Miltenyi Biotech).
Cell phenotyping by flow cytometry and intracellular cytokine staining Anti-CCR7 PE was purchased from R&D systems (Minneapolis, MN, USA), and anti-CD39 PE was from Serotec (Oxford, UK). Anti-Foxp3 (clone PCH101) and anti-IL-17A PE were obtained from eBiosciences (San Diego, CA, USA) and anti-Foxp3 (clone 259D) was from Biolegend (San Diego, CA, USA). Anti-IL-2 APC was from Miltenyi Biotech. All other fluorochromeconjugated monoclonal antibodies and isotype controls were purchased from BD Pharmingen (San Jose, CA, USA). For intracellular cytokine staining, cells were re-stimulated on day 6 of iRBC:PBMC co-culture for 5 hours with phorbol 12-myristate 13-acetate (PMA) (50 ng/ml) and ionomycin (1 mg/ml) (both Sigma) in the presence of brefeldin A (eBioscience) for the last 4 hours. Cells were washed with PBS and incubated with antibodies diluted in PBS/10% HS/0.01% NaN 3 (sodium azide) for 30 min on ice. Intracellular staining for Foxp3, CTLA-4 and cytokines was performed using the eBioscience fixation/permeabilization buffer kit. A minimum of 10 5 events in the lymphocyte gate was acquired using a FACScalibur flow cytometer for 4-colour analysis and on a FACSAria for 5 to 6-colour analysis, and analyzed using WEASEL software (WEHI, Melbourne, Australia). Cells were gated first based on forward and side scatter to excluded dead cells and cell debris. Cells in the lymphocyte gate were then further gated based on forward scatter (to exclude monocytes) versus CD4 expression. Whenever possible, a CD3 stain was included as well to ensure that gated CD4 + cells were indeed T cells. Phenotyping of monocytes was carried out by gating on CD14 + cells that were negative for other lineage markers (CD3, CD19, CD56). All histograms and dot plots are depicted in log scale.
CFSE proliferation
CFSE labeling was employed to distinguish between dividing and non-dividing cells [94] . Freshly isolated PBMCs were resuspended at 10 6 cells/ml in PBS/0.1% FCS and incubated with 0.4 mM CFSE (Molecular Probes, Invitrogen) for 5 minutes at 37uC before staining was quenched with ice-cold RPMI/10% FCS. Cells were washed and set up as described above.
Inhibition assays with anti-MHC class II and cytokine receptors-blocking antibodies
To examine the effect of cytokines, PBMCs were pre-incubated for 1 h at 37uC with blocking antibodies directed against human IFNcR 1 (mIgG 1 , clone 92101), IL-2R alpha (mIgG 1 , clone 22722), IL-6R (polyclonal goat IgG), IL-10R alpha (mIgG 1 , clone 37607) or TGFb1,2,3 (mIgG 1 , clone 1D11) (all R&D Systems). MHC class II dependency was determined using anti-HLA DR mAb (mIgG 2a , clone L243; BD Pharmingen). Normal goat IgG, mIgG 1 or mIgG 2a were used as isotype controls. All antibodies were sodium azide free. iRBC-PBMC co-cultures for each donor were set up in triplicate.
Assays for cytokines
Supernatants were collected at indicated time points and stored at 220uC until assayed in duplicate for cytokines using Cytokine ELISA OptEIA kits (BD Pharmingen) according to the manufacturer's recommendations.
RNA extraction and quantitative real-time RT-PCR analysis
Total RNA was isolated from a minimum of 10 5 iRBCstimulated total PBMCs or MACS-sorted CD4 +
CD25
2 and CD4 + CD25 hi T cells using the RNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer's recommendations. cDNA was synthesized using multiscribe reverse transcriptase and random hexamer primers in the presence of RNase inhibitor (Applied Biosystems, Foster City, CA) at 42uC for 15 min, followed by 5 min at 99uC. Foxp3, IL-10, TGFb and 18SrRNA-specific primers and TaqMan probes were designed using Primer Express software (Applied Biosystems) and synthesized by Geneworks (primers) and Applied Biosystems (probes) ( Table 1) . Quantitative real-time PCR was performed in duplicate on an ABI PRISM 7900 (Applied Biosystems) as follows: 50uC for 2 min, 95uC for 10 min followed by 40 cycles of 95uC for 15 s and 60uC for 1 min. Results for target genes were normalized to 18SrRNA expression and expressed as fold changes between the cell populations of interest.
Data presentation and statistical analysis
In most graphs depicted in this manuscript, we employed normalization onto control conditions for each donor, to be able to analyze changes in Foxp3 hi or Foxp3 int proportions (measured as percentage of CD4 T cells), surface marker expression levels (measured as median fluorescence intensity (MFI) or percent positive cells) or cytokine levels (measured in pg/ml) independent of variation of absolute values between different human donors. Normalized values are referred to as fold change compared to control conditions. To allow immediate identification, control conditions onto which other data in an experiment were normalized for each donor (value 1) are depicted as white bars, as opposed to black bars for all other conditions throughout. Statistical analysis was carried out using GraphPad Prism software v4 (San Diego, CA, USA). P values were determined by either Wilcoxon's signed rank test for absolute values, or two-tailed paired Student's t-test for normalized values. Three or more groups were compared by repeated-measures one-way ANOVA, followed by the linear trend, Dunnett's or Neuman-Keuls' multiple comparison post test. Correlation analysis was performed using Spearman rank correlation. A P value,0.05 was considered significant. 
